NCT07349186 Oscillometric Versus Intraarterial Blood Pressure Monitoring During Robot-Assisted Prostatectomy
| NCT ID | NCT07349186 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Hamburg-Eppendorf |
| Condition | Intraoperative Hypotension |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2026-01-29 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2026-01-29 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The PROST-BP trial is a prospective, single-center, randomized, patient-blinded, non-inferiority trial investigating whether intermittent oscillometric blood pressure monitoring is non-inferior to continuous intraarterial blood pressure monitoring in reducing intraoperative hypotension in patients having robot-assisted radical prostatectomy.
Eligibility Criteria
Inclusion Criteria: * male patient ≥18 years * scheduled for elective robot-assisted (Da Vinci) radical prostatectomy in steep Trendelenburg position * planned intraarterial blood pressure monitoring Exclusion Criteria: * patients in whom the attending anesthesiologist considers intraarterial blood pressure monitoring to be mandatory for clinical reasons * patients participating in another interventional trial likely to influence intraoperative blood pressure management
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07349186 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Intraoperative Hypotension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07349186 currently recruiting?
Yes, NCT07349186 is actively recruiting participants. Contact the research team at a.bergholz@uke.de for enrollment information.
Where is the NCT07349186 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT07349186 clinical trial?
NCT07349186 is sponsored by University of Hamburg-Eppendorf. The trial plans to enroll 210 participants.